Search results
-
Kola Real: La expansión internacional
Ferré, Miguel; Natividad, GabrielCase PAD-DG-C-406EntrepreneurshipDescribe el caso de la internacionalización de una empresa peruana en varios países de la región, partiendo de unos modestos inicios en Ayacucho (1988). Se puede discutir la similitud o diferencias en la forma de nacer según el contexto de cada país.Starting at €8.20
-
Huawei: A Silent Chinese Telecom Multinational
Zhang, Yingying; Kase, KimioCase SM-1560-ECorporate Governance, Knowledge and CommunicationIn terms of sales, Huawei is the world's fourth-largest maker of network equipment, after Ericsson, Nokia Siemens Networks, and Alcatel-Lucent. It also ranked second in optical networking and third in mobile-network gear in 2008. It is one of the leading global telecommunications solution providers with a revenue of 18.33 billion USD in 2008 and a net income of 1.15 billion USD. Contrary to the typical image of Chinese companies that depicts them...Starting at €8.20
-
Fukushima Daiichi Nuclear Power Station (NPS)
Kase, Kimio; Nonaka, Ikujiro; Independent Investigation CommissioCase SM-1579-EDecision Analysis, Knowledge and Communication, StrategyThe questions may largely fall into two categories: (1) Did Japan or PM Kan and his team cope well with the crisis (i.e., questions regarding efficiency and effectiveness)? And, perhaps more importantly, (2) Have lessons been learned that would help Japan prepare for other natural or man-made catastrophes (i.e., questions regarding learning and knowledge-creation)?Starting at €8.20
-
Kantha Bopha Children's Hospitals: Dr. Beat Richner's Lifework
Olivares, Ignacio; Kase, KimioCase SM-1548-EBusiness Ethics and Corporate Social Responsibility, Leadership and People ManagementDr. Beat Richner, a 62-year-old Swiss pediatrician, set up children's hospitals in 1991 at the behest of the Cambodian King after the devastation brought about by the civil war. By 2009 he has managed to open and run four of them, both in Phnom Penh and Siem Reap. They are almost entirely dependent on private donations, which, collected through his cello concerts and the Kantha Bopha Foundation, largely come from Europe and other parts of the wo...Starting at €8.20
-
Banco Santander - Teaching Note: CEOs as Leaders and Strategy Designers
Kase, Kimio; Marinelli, FedericoTeaching Note SMT-62-ECorporate Governance, Service and Operations ManagementTeaching note for Banco Santander SM-1534-EStarting at €0.00
-
Banco Santander: CEOs as Leaders and Strategy Designers
Kase, Kimio; Marinelli, FedericoCase SM-1534-ECorporate Governance, Service and Operations ManagementThe case describes Santander's three pronged business model, including the strategic use of IT and the persuance of the growth in size through cross-border M&A strategy, while concentrating single-mindedly on the retail banking activities. CEOs cognition process is analyzed based on Kase and Jacopin 2007 and Kase et al. 2005.Starting at €8.20
-
Norio Ohga: The Fifth President of Sony Corporation
Sáez, Francisco J.; Riquelme, Hernán; Kase, KimioCase DG-1481-EStrategyThe case analyses the conceptual scheme or model identified in Norio Ohga's management style, which we call the proto-image of the firm (PIF) approach. Sony's success in its diversification strategy is explained on the basis of PIF.Starting at €8.20
-
Chihiro Kanagawa, President of Shin-Etsu Chemical
Sáez, Francisco J.; Riquelme, Hernán; Kase, KimioCase DG-1483-EStrategyThis case examines the professional career of Chihiro Kanagawa, and shows how he turned Shin-Etsu Chemicals into a major international player in a sector in which Japanese companies had traditionally been uncompetitive. The case illustrates Kanagawa's dynamic management style and the value system on which it is based and we call the profit- arithmetic (PA) approach. Shin-Etsu Chemical's success by not spending money on projects not generating imm...Starting at €8.20
-
ABC Pharmaceuticals
Herzlinger, Regina E.; Sparks, Erik R.Case HBS-313041-EKnowledge and CommunicationThis case asks students to price a new drug which is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S.Starting at €8.20
-
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315045-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €8.20